Drug
AXS-07 clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 4
- first study started
- 2019
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2019 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses AXS-07 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Initiating Early Control of Migraine Pain and Associated SymptomsCompletedPhase 3Axsome Therapeutics, Inc.NCT04163185Written as AXS-07 (MoSEIC meloxicam and rizatriptan)
- Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)CompletedPhase 3Axsome Therapeutics, Inc.NCT05550207Written as AXS-07 (meloxicam-rizatriptan)
- Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)CompletedPhase 3Axsome Therapeutics, Inc.NCT04068051Written as AXS-07
- Maximizing Outcomes in Treating Acute MigraineCompletedPhase 3Axsome Therapeutics, Inc.NCT03896009Written as AXS-07 (MoSEIC meloxicam and rizatriptan)